Skip to main content

Elevance Health, Inc.

ELV
Exchange
NYSE
Industry
Hospital & Medical Service Plans
SEC CIK
0001156039

In the last 90 days, Elevance Health, Inc. insiders filed 2 open-market purchases and 0 sales; 1,614 institutions reported holding it in 13F filings for Q2 2026, worth $76.8B in total; superinvestors Harris Associates (Oakmark) and Baupost Group hold it.

Holders of 5% or more of ELV

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Elevance Health, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ELV
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A7.80%17.7M shares–Apr 17, 20251 filingApr 17, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

3 Schedule 13D and 13G filings on Elevance Health, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ELV
Filed (ET)FilerFormStakeChangeEvent dateFiling
Apr 29, 20266:22 PM ETVanguard Capital Management LLC13G7.13%16.6M sharesNewMar 31, 2026SEC
Mar 26, 20266:03 PM ETVanguard Group Inc13G/A0.00%0 shares−10.13 ppfrom 10.13%Below 5%Mar 13, 2026SEC
May 7, 202510:07 AM ETVanguard Group Inc13G/A10.13%22.9M shares–Apr 30, 2025SEC
Apr 17, 20259:35 AM ETBlackRock, Inc.13G/A7.80%17.7M shares–Mar 31, 2025SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Jan 28, 20215:56 PM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Elevance Health, Inc. shares.

No Form 144 notices for Elevance Health, Inc. are on file.